Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely pitavastatin 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing pitavastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 2 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pitavastatin 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pitavastatin calcium |
Is a |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pitavastatin allergy |
Causative agent (attribute) |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction caused by pitavastatin |
Causative agent (attribute) |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 1 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 2 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 2 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 4 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 1 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 2 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin 4 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pitavastatin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pitavastatin calcium |
Is modification of (attribute) |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only pitavastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only pitavastatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin (as pitavastatin calcium) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pitavastatin (as pitavastatin calcium) 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pitavastatin (as pitavastatin calcium) 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pitavastatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |